Cargando…

Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings

Background: The tumor microenvironment (TME) of oral squamous cell carcinoma (OSCC) is associated with immune suppression, one of the pathways being the programmed death receptor 1 (PD-1) and its ligands (PD-L1/PD-L2). Checkpoint inhibitors of PD-1/PD-L1, like pembrolizumab, have been recently appro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dobriyan, Alex, Gluck, Iris, Alon, Eran, Barshack, Iris, Yahalom, Ran, Vered, Marilena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oral Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757715/ https://www.ncbi.nlm.nih.gov/pubmed/35048002 http://dx.doi.org/10.3389/froh.2021.653104

Ejemplares similares

Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
Publicado: (2022)

Oral erythroplakia and oral erythroplakia-like oral squamous cell carcinoma – what’s the difference?
por: Öhman, Jenny, et al.
Publicado: (2023)

Airway management following head and neck microvascular reconstruction: is tracheostomy mandatory?
por: Madgar, Ory, et al.
Publicado: (2021)

Preliminary results from a Phase I/II study of epacadostat (incb024360) in combination with pembrolizumab in patients with selected advanced cancers
por: Gangadhar, Tara C, et al.
Publicado: (2015)

Clinical, dermoscopic and histopathologic findings of retiform hemangioendothelioma
por: Mota, Amanda, et al.
Publicado: (2013)

A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma
por: Dummer, Reinhard, et al.
Publicado: (2015)

Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models
por: Feldman, Tal, et al.
Publicado: (2020)

Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
por: Chen, Yulong, et al.
Publicado: (2023)

Correction: Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models
por: Feldman, Tal, et al.
Publicado: (2020)

Editorial: The Translational and Therapeutic Potential of the Tumor Microenvironment in Oral Cancer
por: Hunter, Keith D., et al.
Publicado: (2021)

Neoadjuvant treatment: the MD Anderson experience
por: Hortobagyi, GN
Publicado: (2005)

Hypoxic Transformation of Immune Cell Metabolism Within the Microenvironment of Oral Cancers
por: Chaudhary, Amrita, et al.
Publicado: (2020)

MR guided focused ultrasound as a treatment tool for essential and Parkinsonian tremor
por: Zaaroor, Menashe, et al.
Publicado: (2015)

Multiparametric CMR assessment of RV apical versus septal Pacing Study (MAPS) - preliminary acute hemodynamic findings
por: Ainslie, Mark, et al.
Publicado: (2013)

Preliminary findings on cancer incidence in HIV-infected persons from six countries in Central and South America and the Caribbean
por: Masys, DR, et al.
Publicado: (2009)

Alternatives to inpatient treatment in the acute phase
por: Hauth, Iris
Publicado: (2007)

Combination therapy with ipilimumab and electrochemotherapy: preliminary efficacy results and correlation with immunological parameters
por: Simeone, Ester, et al.
Publicado: (2014)

Biomarkers and predictive factors of response to neoadjuvant treatment
por: Dowsett, M, et al.
Publicado: (2009)

Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma
por: Galore-Haskel, Gilli, et al.
Publicado: (2017)

Evaluation of Proton MR Spectroscopy for the Study of the Tongue Tissue in Healthy Subjects and Patients With Tongue Squamous Cell Carcinoma: Preliminary Findings
por: Boussida, Salem, et al.
Publicado: (2022)

Histopathology of the exanthema in DRESS in correlation with markers of severe systemic involvement
por: Gonçalo, Margarida, et al.
Publicado: (2014)

Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
por: Satish, Tejus, et al.
Publicado: (2021)

Crosstalk between cancer stem cells and the tumor microenvironment drives progression of premalignant oral epithelium
por: Polverini, Peter J., et al.
Publicado: (2023)

Schroth treatment results in AIS at high risk for surgery - 2 case studies
por: Sulam, Lior Neuhaus, et al.
Publicado: (2014)

Proteomic patterns associated with response to breast cancer neoadjuvant treatment
por: Shenoy, Anjana, et al.
Publicado: (2020)

A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC
por: Lemmon, Christopher A., et al.
Publicado: (2022)

Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United States
por: Tian, Wentao, et al.
Publicado: (2023)

Clinical and histopathological correlation of oral malignancy and potentially malignant disorders based on a screening program at high-risk population in Tamil Nadu, India
por: Iyer, Kiran, et al.
Publicado: (2023)

Inducing a tolerogenic microenvironment within tissues
por: Cobbold, Stephen P
Publicado: (2011)

The role of the tumor microenvironment in breast cancer progression
por: Min, H, et al.
Publicado: (2005)

Tumor microenvironment controls the rate of cancer progression and metastasis
por: Kalluri, Raghu
Publicado: (2010)

Cytomics of the tumour microenvironment: therapeutic targeting (keynote lecture)
por: Smith, Paul
Publicado: (2015)

Surgical management of the breast and axilla after neoadjuvant treatment: the role of sentinel node biopsy
por: Mamounas, EP
Publicado: (2009)

Patients' view of seclusion – preliminary report
por: Keski-Valkama, Alice, et al.
Publicado: (2007)

Vaccination Coverage among Immunocompromised Patients in a Large Health Maintenance Organization: Findings from a Novel Computerized Registry
por: Shapiro Ben David, Shirley, et al.
Publicado: (2022)

Targeting non-viral vectors to tumor cells and the tumor microenvironment
por: Moura, Vera, et al.
Publicado: (2010)

Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor
por: Coleman, RE
Publicado: (2009)

S188: CAR-T CELLS SHAPE THE IMMUNOLOGICAL POTENTIAL OF THE TUMOR MICROENVIRONMENT
por: Frede, Julia, et al.
Publicado: (2023)

Infarct size is overestimated by contrast-enhanced CMR in the acute phase but not at 7 days when compared with histopathology
por: Jablonowski, Robert, et al.
Publicado: (2014)

Histopathologic changes following neoadjuvant chemotherapy in various malignancies
por: Sethi, Divya, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gnvtuuvmtfhvk3bo1gp9dhquds